CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Grant or award SVP & Chief Commercial Officer acquired 30,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 60,966 shares at $18.72 ($1,141,003)
- 4 Open-market sale EVP & Chief Financial Officer sold 8,532 shares at $18.72 ($159,712)
- 4 Open-market sale SVP, General Counsel & Sec. sold 3,660 shares at $18.71 ($68,473)
- 4 Open-market sale SVP, Business Development sold 8,525 shares at $18.72 ($159,605)
- 4 Exercise or conversion SVP & Chief Commercial Officer acquired 20,000 shares (option exercise)
- 4 Open-market sale President and CEO sold 191,760 shares at an average $15.30 ($2,933,127)
- 4 Open-market sale EVP & Chief Financial Officer sold 9,155 shares at $15.35 ($140,494)
- 4 Open-market sale SVP, General Counsel & Sec. sold 10,367 shares at $15.20 ($157,565)
- 4 Open-market sale SVP, Business Development sold 8,568 shares at $15.26 ($130,777)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
Page 11 of 29 · 579 filings